215 related articles for article (PubMed ID: 11067885)
1. Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity.
Nakayama M; Kayagaki N; Yamaguchi N; Okumura K; Yagita H
J Exp Med; 2000 Nov; 192(9):1373-80. PubMed ID: 11067885
[TBL] [Abstract][Full Text] [Related]
2. Multiple pathways of TWEAK-induced cell death.
Nakayama M; Ishidoh K; Kayagaki N; Kojima Y; Yamaguchi N; Nakano H; Kominami E; Okumura K; Yagita H
J Immunol; 2002 Jan; 168(2):734-43. PubMed ID: 11777967
[TBL] [Abstract][Full Text] [Related]
3. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis.
Felli N; Pedini F; Zeuner A; Petrucci E; Testa U; Conticello C; Biffoni M; Di Cataldo A; Winkles JA; Peschle C; De Maria R
J Immunol; 2005 Aug; 175(3):1464-72. PubMed ID: 16034083
[TBL] [Abstract][Full Text] [Related]
4. [Cytotoxicity of IFN-gamma-activated dendritic cells to freshly isolated acute myeloid leukemia cells].
Shi J; Zhang Y; Su JY; Li X; Pu Q; Ikeda K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1071-5. PubMed ID: 16403283
[TBL] [Abstract][Full Text] [Related]
5. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells.
Kaplan MJ; Lewis EE; Shelden EA; Somers E; Pavlic R; McCune WJ; Richardson BC
J Immunol; 2002 Nov; 169(10):6020-9. PubMed ID: 12421989
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.
Griffith TS; Wiley SR; Kubin MZ; Sedger LM; Maliszewski CR; Fanger NA
J Exp Med; 1999 Apr; 189(8):1343-54. PubMed ID: 10209050
[TBL] [Abstract][Full Text] [Related]
7. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.
Liu S; Yu Y; Zhang M; Wang W; Cao X
J Immunol; 2001 May; 166(9):5407-15. PubMed ID: 11313377
[TBL] [Abstract][Full Text] [Related]
8. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
[TBL] [Abstract][Full Text] [Related]
9. Monocytes stimulated with group B streptococci or interferons release tumour necrosis factor-related apoptosis-inducing ligand.
Halaas Ø; Liabakk NB; Vik R; Beninati C; Henneke P; Sundan A; Espevik T
Scand J Immunol; 2004; 60(1-2):74-81. PubMed ID: 15238075
[TBL] [Abstract][Full Text] [Related]
10. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages.
Kaplan MJ; Ray D; Mo RR; Yung RL; Richardson BC
J Immunol; 2000 Mar; 164(6):2897-904. PubMed ID: 10706675
[TBL] [Abstract][Full Text] [Related]
11. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
12. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
[TBL] [Abstract][Full Text] [Related]
13. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.
Philip R; Epstein LB
Nature; 1986 Sep 4-10; 323(6083):86-9. PubMed ID: 3092113
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.
Nakayama M; Ishidoh K; Kojima Y; Harada N; Kominami E; Okumura K; Yagita H
J Immunol; 2003 Jan; 170(1):341-8. PubMed ID: 12496418
[TBL] [Abstract][Full Text] [Related]
16. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
[TBL] [Abstract][Full Text] [Related]
17. Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies.
Nakayama M; Harada N; Okumura K; Yagita H
Biochem Biophys Res Commun; 2003 Jul; 306(4):819-25. PubMed ID: 12821115
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
19. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages.
Halaas O; Vik R; Ashkenazi A; Espevik T
Scand J Immunol; 2000 Mar; 51(3):244-50. PubMed ID: 10736093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
